Testicular cancer is the most common cancer in young men. Urology nurses are familiar with the surgical aspects of testicular cancer treatments: however, they may not be familiar with the complex medical management, treatment option decisions, and lifelong follow-up for this highly curable malignancy. This presentation enables the urology practitioner to better understand the health and psychosocial issues of men diagnosed with TGCT before, during, and after treatment.

Contact hours available until 10/26/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Gina Powley - Astellas/Medivation speaker bureau, Ferring Pharmaceuticals speaker bureau
• Leanne Schimke, MSN, CRNP, CUNP - Consultant: Bayer, Speaker's Bureau: Bayer
• Valre Welch, MSN, CPNP - Holister Continence Care Advisory Board; Speaker for Hollister Incontinence Workshops

Speaker Disclosures:
There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
1. Describe the staging and classifications for testicular cancer.
2. Recognize the treatment options, chemotheraputic regimens, and side effects in the treatment of testicular cancer.
3. Comprehend the importance of long-term follow-up for testicular cancer survivors.

Barbara H. Zoltick MSN, CURN

Appearances